Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
October 24, 2018
Bioinformatics Analysis of Whole Exome Sequencing Data
Peter J Ulintz, Weisheng Wu, Chris M Gates
Molecular & Cellular Proteomics : MCP
|
December 3, 2005
Improved classification of mass spectrometry database search results using newer machine learning approaches
Peter J Ulintz, Ji Zhu, Zhaohui S Qin, et al.
Molecular & Cellular Proteomics : MCP
|
September 18, 2007
Investigating MS2/MS3 matching statistics: a model for coupling consecutive stage mass spectrometry data for increased peptide identification confidence
Peter J Ulintz, Bernd Bodenmiller, Philip C Andrews, et al.
Nature Communications
|
September 9, 2020
FastClone is a probabilistic tool for deconvoluting tumor heterogeneity in bulk-sequencing samples
Yao Xiao, Xueqing Wang, Hongjiu Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 6, 2017
Lymph Node Metastases in Colon Cancer Are Polyclonal
Peter J Ulintz, Joel K Greenson, Rong Wu, et al.
Molecular & Cellular Proteomics : MCP
|
August 7, 2008
Global topology analysis of pancreatic zymogen granule membrane proteins
Xuequn Chen, Peter J Ulintz, Eric S Simon, et al.
Journal of Proteome Research
|
December 17, 2008
Comparison of MS(2)-only, MSA, and MS(2)/MS(3) methodologies for phosphopeptide identification
Peter J Ulintz, Anastasia K Yocum, Bernd Bodenmiller, et al.
Scientific Reports
|
April 3, 2020
Heterogeneity at the invasion front of triple negative breast cancer cells
Koh Meng Aw Yong, Peter J Ulintz, Sara Caceres, et al.
Hepatology (Baltimore, Md.)
|
September 14, 2017
Nuclear lamina genetic variants, including a truncated LAP2, in twins and siblings with nonalcoholic fatty liver disease
Graham F Brady, Raymond Kwan, Peter J Ulintz, et al.
Frontiers in Oncology
|
September 13, 2021
RhoC Modulates Cell Junctions and Type I Interferon Response in Aggressive Breast Cancers
Hannah G Abraham, Peter J Ulintz, Laura Goo, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Methods in Molecular Biology (Clifton, N.J.)
|
October 24, 2018
Bioinformatics Analysis of Whole Exome Sequencing Data
Peter J Ulintz, Weisheng Wu, Chris M Gates
Molecular & Cellular Proteomics : MCP
|
December 3, 2005
Improved classification of mass spectrometry database search results using newer machine learning approaches
Peter J Ulintz, Ji Zhu, Zhaohui S Qin, et al.
Molecular & Cellular Proteomics : MCP
|
September 18, 2007
Investigating MS2/MS3 matching statistics: a model for coupling consecutive stage mass spectrometry data for increased peptide identification confidence
Peter J Ulintz, Bernd Bodenmiller, Philip C Andrews, et al.
Nature Communications
|
September 9, 2020
FastClone is a probabilistic tool for deconvoluting tumor heterogeneity in bulk-sequencing samples
Yao Xiao, Xueqing Wang, Hongjiu Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 6, 2017
Lymph Node Metastases in Colon Cancer Are Polyclonal
Peter J Ulintz, Joel K Greenson, Rong Wu, et al.
Molecular & Cellular Proteomics : MCP
|
August 7, 2008
Global topology analysis of pancreatic zymogen granule membrane proteins
Xuequn Chen, Peter J Ulintz, Eric S Simon, et al.
Journal of Proteome Research
|
December 17, 2008
Comparison of MS(2)-only, MSA, and MS(2)/MS(3) methodologies for phosphopeptide identification
Peter J Ulintz, Anastasia K Yocum, Bernd Bodenmiller, et al.
Scientific Reports
|
April 3, 2020
Heterogeneity at the invasion front of triple negative breast cancer cells
Koh Meng Aw Yong, Peter J Ulintz, Sara Caceres, et al.
Hepatology (Baltimore, Md.)
|
September 14, 2017
Nuclear lamina genetic variants, including a truncated LAP2, in twins and siblings with nonalcoholic fatty liver disease
Graham F Brady, Raymond Kwan, Peter J Ulintz, et al.
Frontiers in Oncology
|
September 13, 2021
RhoC Modulates Cell Junctions and Type I Interferon Response in Aggressive Breast Cancers
Hannah G Abraham, Peter J Ulintz, Laura Goo, et al.
Page
of 3